MarketBeat reports consensus rating and price target for Eikon Therapeutics, Inc., alongside rating updates from Cantor Fitzgerald and Manufacturers Life Insurance Company.
1 report, 1 independent
Updated Aug 15
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MarketBeat reports consensus rating and price target for Eikon Therapeutics, Inc., alongside rating updates from Cantor Fitzgerald and Manufacturers Life Insurance Company.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Cantor Fitzgerald
American financial services company
- The event reports that Brooke Rollins serves as Trump's Agriculture Secretary and notes that Lutnick previously ran Cantor Fitzgerald.
- Agilysys CEO Ramesh Srinivasan sold significant company shares, with the transaction disclosed via filings with the SEC, concurrent with a rating from Cantor Fitzgerald.
-
MarketBeat
American personal finance blog
Related events
- Cantor Fitzgerald increased its price target and rating for Hyperliquid Strategies, while MarketBeat provided consensus rating data.
- MarketBeat reported on analyst coverage for IONQ, noting that Needham reiterated its buy rating, while Cantor Fitzgerald set a $70.00 price target and reiterated its overweight rating.
- Cantor Fitzgerald reiterated an overweight rating on BioPharma shares, reducing the target price and setting a buy rating.
- Cantor Fitzgerald raised its price target and gave an overweight rating for SOL Strategies Inc. on October 11, 2026.
- MarketBeat aggregated consensus ratings and average price targets for Atour Lifestyle Holdings Limited. Morgan Stanley provided an overweight rating and price target.